Triathlon Medical Ventures Triathlon Medical Ventures
Triathlon Medical Ventures Triathlon Medical Ventures Triathlon Medical Ventures
Triathlon Medical Ventures - Homepage
Triathlon Medical Ventures - Team
Triathlon Medical Ventures - Investment Focus
Triathlon Medical Ventures - Investment Strategy
Triathlon Medical Ventures - Investment Criteria
Contact Triathlon Medical Ventures - Evaluation Process
Triathlon Medical Ventures - Portfolio
Triathlon Medical Ventures - News
Triathlon Medical Ventures - Links
Contact Contact Triathlon Medical Ventures

Triathlon Medical Ventures

 

 

 

 

 


Whether you're an entrepreneur or a venture capitalist, you'll find a warm welcome at Triathlon Medical Ventures. Prior to opening our doors in 2004, Triathlon's team has been investing in life science business opportunities for more than fifteen years. And we are also industry veterans, experienced at growing medical device and biotechnology companies from the inside out - as owners, directors and operational managers.

Triathlon Medical Ventures is a Midwest-based venture capital firm that invests exclusively in the life sciences. We provide equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs.

We are geographically focused on early stage opportunities in the Midwest but will also invest in later stage companies nationwide. We are headquartered in Cincinnati, with offices and partners in Indianapolis and Louisville. The partners are industry veterans with extensive experience as both operational managers and venture capitalists.

We invite you now to explore these web pages and consider how Triathlon Medical Ventures might be the right partner for your investment opportunity.



RECENT NEWS

Click here for Triathlon Medical Ventures related videos on YouTube

October 3, 2013
Kent Oyler: George Emont was the quiet giant of Louisville’s entrepreneurial community (Link)

June 4, 2013
Akebia Closes $41 Million Series C

July 16, 2012
Juventas Therapeutics Raises $22.2 Million Series B Financing (Link)

July 9, 2012
Peter Meldrum Joins the Endocyte Board of Directors (PDF)

May 30, 2012
Wound healing startup SironRX hires new CEO, gets OK on clinical trial (Link)

May 16, 2012
Mitralign Raises $35 Million Series D Financing (Link)

April 16, 2012
Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate Vintafolide (EC145) (PDF)

March 20, 2012
Aerpio Announces Positive Phase 1 Data on First-in-class Tie2 Activator, AKB-9778, in Development for Diabetic Macular Edema (PDF)

January 9, 2012
New Company, Aerpio Therapeutics, Created to Advance Novel Tie-2 Activators and HIF-1a Stabilizers for Multiple Diseases (PDF)

August 15, 2011
Wound therapy company SironRX closes $3.4M series A investment (Link)

 
 
Copyright © 2004 - Triathlon Medical Ventures - All Rights Reserved Web Site Credits Legal Notices & Privacy Policy